Speciality: Orthopedics
Description:
Welcome to our podcast, where today we’re focusing on what to expect after joint replacement surgery. Recovery is a journey that involves both physical healing and adapting to new routines. In the first few days, managing pain and swelling is crucial, often with medication and gentle movement. Physiotherapy usually starts soon after surgery to help restore strength and flexibility. Most patients gradually regain independence within a few weeks, but full recovery can take several months. It’s important to follow your doctor’s advice, attend all follow-up appointments, and be patient with your progress. Remember, every recovery is unique, and steady improvements are a positive sign. Stay informed and take an active role in your healing for the best results.
See More Webinars @ Hidoc Webinars
1.
SCOTUS Grapples With Multibillion-Dollar Lawsuits Over Roundup Cancer Claims
2.
Benign or Malignant? No Way to Tell Radiologically
3.
Access to GLP-1 medications associated with a lower risk of colorectal cancer in people with type 2 diabetes: JAMA.
4.
FDA Approves Iberdomide Combo for Multiple Myeloma
5.
The response of bipolar patients to lithium may be predicted by ancestry.
1.
Emerging Therapies Using Immune-Engineered Cancer Eradication Platforms
2.
Digital Oncology Navigation Systems for Coordinated Multidisciplinary Cancer Care
3.
Fatigue, Vitality, and Quality of Life in Hematologic Disorders
4.
Engineered Red Blood Cell Therapeutics: Emerging Applications
5.
Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
2.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
3.
Case-Based Learning: Oncology
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation